Product image of Kaleorid (Potassium Chloride) supplied by GNH India

Kaleorid

Active Ingredient:
Potassium Chloride
Origin:
EU

Kaleorid (Potassium Chloride)

Potassium Chloride, the active ingredient in Kaleorid, is an electrolyte presented as an oral formulation for oral use. It treats potassium deficiency and hypokalemia by restoring normal serum potassium levels in patients who require electrolyte replacement. It is indicated for patients with documented low potassium levels and is commonly used in acute care and chronic management settings.

GNH India supplies Kaleorid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑regulated manufacturers to ensure quality and compliance.

Manufacturer / TM Owner

Karo Pharma Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kaleorid (potassium chloride) is used to correct electrolyte disturbances related to low potassium levels.

  • Hypokalemia: restores serum potassium to the normal range, reducing muscle weakness and cardiac arrhythmias.
  • Potassium deficiency: provides essential potassium ions to maintain cellular function and nerve conduction.
  • Cardiac arrhythmia risk due to low potassium: helps stabilize cardiac electrical activity and prevent arrhythmic events.

How It Works

  • Potassium chloride dissociates in the gastrointestinal tract, releasing potassium ions that are absorbed primarily in the small intestine. The increased extracellular potassium concentration raises serum potassium levels, correcting hypokalemia and supporting the electrochemical gradients required for nerve impulse transmission, muscle contraction, and cardiac electrophysiology.

Side Effects

Oral potassium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild to moderate feeling of stomach upset.
  • Abdominal cramping: discomfort or pain in the abdomen.
  • Diarrhea or constipation: altered bowel habits.
  • Taste disturbance: metallic or salty taste perception.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerously high serum potassium that can affect heart rhythm.
  • Cardiac arrhythmia: irregular heartbeat potentially leading to syncope.
  • Allergic reaction: rash, itching, swelling, or anaphylaxis in rare cases.

Precautions & Warnings

When prescribing Kaleorid, clinicians should consider several safety measures.

  • Monitor serum potassium: check levels before initiation and periodically during therapy.
  • Adjust dose in renal impairment: reduced kidney function can increase risk of hyperkalemia.
  • Avoid in existing hyperkalemia: contraindicated when serum potassium is already elevated.
  • Caution with ACE inhibitors or potassium‑sparing diuretics: these agents may potentiate potassium accumulation.
  • Use ECG monitoring in high‑risk patients: detect potential cardiac effects early.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Potassium chloride can interact with several medications, influencing potassium balance.

Major Interactions (Avoid)

  • ACE inhibitors or ARBs: may cause additive hyperkalemia.
  • Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia.
  • Trimethoprim: can reduce renal potassium excretion.

Moderate Interactions (Monitor Closely)

  • Digoxin: elevated potassium can alter digoxin toxicity risk.
  • NSAIDs: may impair renal potassium handling.
  • Beta‑blockers: may mask symptoms of hyperkalemia.
  • Lithium: concurrent use may affect lithium clearance.

Frequently Asked Questions

Kaleorid contains potassium chloride, an oral electrolyte supplement used to treat hypokalemia and potassium deficiency. It helps restore normal serum potassium levels, supporting muscle function, nerve conduction, and cardiac rhythm in patients with low potassium.

After oral administration, potassium chloride dissociates to release potassium ions, which are absorbed in the small intestine. The added potassium raises extracellular concentrations, correcting low serum levels and re‑establishing the electrochemical gradients essential for cellular activities such as nerve signaling and muscle contraction.

The appropriate dose of Kaleorid is determined by the prescribing clinician based on the patient’s serum potassium level, renal function, and overall clinical condition. Healthcare professionals adjust the amount to achieve target potassium concentrations while minimizing the risk of hyperkalemia.

Safety data for Kaleorid in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Kaleorid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaleorid provides potassium chloride, the most common and bioavailable form of oral potassium supplementation. Compared with potassium gluconate or citrate, chloride offers a higher elemental potassium content per gram, which can be advantageous when rapid correction of hypokalemia is needed.

Kaleorid should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Kaleorid is taken orally, usually with a full glass of water. The tablet or liquid should be swallowed whole and not chewed, unless the specific formulation instructions indicate otherwise. Administration timing may be adjusted based on the prescriber’s guidance.

The most serious risk is severe hyperkalemia, which can cause cardiac arrhythmias, muscle weakness, or even cardiac arrest. Patients should be monitored for signs of elevated potassium, especially if they have renal impairment or are taking other potassium‑increasing medications.

Kaleorid should be avoided in patients with known hyperkalemia, severe renal failure, or those taking medications that significantly raise potassium levels such as potassium‑sparing diuretics, ACE inhibitors, or ARBs, unless closely monitored by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Potassium Chloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT